Robotic Surgery - A Paradigm Shift For Head and Neck Cancers

October 25, 2010

HemOnc Today

HemOncToday details how robotic surgery, like the TORS procedure developed at Penn, is a paradigm shift for the treatment of head and neck cancers. Conventional surgery to treat these cancers is an extremely invasive procedure. In an interview with the publication, Bert W. O'Malley, Jr. MD, Gabriel Tucker professor and chair of the Department of Otorhinolaryngology - Head and Neck Surgery said traditionally "this is a 14-hour procedure that requires a 7- to 10-day stay in the hospital, and leaves the patient disfigured." Along with Gregory S. Weinstein, MD, vice chairman and director, Division of Head & Neck Surgery, Dr. O'Malley developed the minimally-invasive TORS approach, which received FDA approval in January 2010 and they are now training surgeons from all over the world on the TORS system… READ MORE

Related Resources